Christiaan M Roosendaal

Years Active: 2023-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Alyssa A Toorop, Zoé Léonie Elise van Kempen, Maurice Steenhuis, Jessica Nielsen, L G F Sinnige, Gert van Dijk, Christiaan M Roosendaal, Edo P J Arnoldus, Elske Hoitsma, Birgit I Lissenberg-Witte, Brigit A de Jong, Bob W van Oosten, Eva M M Strijbis, Bernard M J Uitdehaag, Theo Rispens, Joep Killestein, null null
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (2023)
Alyssa A Toorop, Zoë Ygj van Lierop, Liza My Gelissen, Elske Hoitsma, Esther Mpe Zeinstra, Luuk C van Rooij, Caspar Ep van Munster, Anke Vennegoor, Jop P Mostert, Beatrijs Ha Wokke, Nynke F Kalkers, Erwin Lj Hoogervorst, Jeroen Jj van Eijk, Christiaan M Roosendaal, Jolijn J Kragt, Marijke Eurelings, Jessie van Genugten, Jessica Nielsen, Lgf Sinnige, Mark E Kloosterziel, Edo Pj Arnoldus, Gert W van Dijk, Willem H Bouvy, Mark Hj Wessels, Lynn Boonkamp, Eva M M Strijbis, Bob W van Oosten, Brigit A De Jong, Birgit I Lissenberg-Witte, Frederik Barkhof, Bastiaan Moraal, Charlotte E Teunissen, Theo Rispens, Bernard Mj Uitdehaag, Joep Killestein, Zoé Léonie Elise van Kempen
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS). Journal of neurology, neurosurgery, and psychiatry (2023)

Christiaan M Roosendaal.css-eqlu8i{font-size:small;padding-left:4px;}